Robert Hutchinson has many years of broad financial experience, having spent 28 years at KPMG. He was appointed partner in 1999 and specialised in the audit of banking and fund clients. He led the firms fund and private equity practices for seven years and served as Head of Audit for KPMG in the Channel Islands for five years until 2013.
Robert retired from practice in 2014 and is a Fellow of the Institute of Chartered Accountants in England and Wales. He served as President of the Guernsey Society of Chartered and Certified Accountants between 2007 and 2009.
Jeremy Tigue - Chairman
Jeremy Tigue has more than 30 years’ investment experience. He joined F&C Management in 1981 and was the fund manager of Foreign & Colonial Investment Trust PLC from 1997 to 2014. He was a Director of the Association of Investment Companies from 2003 to 2013 and was Chairman of the Institutional Shareholder Committee from 2006 to 2008. He is a Director of ICG Enterprise Trust PLC, The Mercantile Investment Trust plc, The Monks Investment Trust PLC and Standard Life Equity Income Trust PLC.
Ellen is a senior executive with 25 years of international experience in the healthcare industry (biopharmaceuticals, medical devices, public health). Ellen is currently the Chief Medical Officer and Executive Vice President, Research & Development for BD (Becton, Dickinson and Company), a leading global medical technology company. Ellen was previously with GlaxoSmithKline, plc, having served as the Senior Vice President and Chief Medical Officer (CMO) since 2008 and more recently working in the Office of the CEO as Senior Medical Advisor and Global Head of Neglected Tropical Diseases. Ellen is a graduate of Harvard University (Biochemical Sciences) and obtained her medical degree from the Johns Hopkins School of Medicine. She has medical qualifications in general surgery (Johns Hopkins) and ophthalmology (the Wilmer Institute, Johns Hopkins). Finally, Ellen earned her Master’s Degree in Health Sciences from the Johns Hopkins Bloomberg School of Public Health as a Carnegie-Mellon Physician Public Health Fellow.
Nicholas Moss is the founder of Virtus Trust, a successful and award winning international fiduciary and investment services business headquartered in Guernsey, and with operations in several countries including the US, UK, New Zealand and the Cayman Islands. Nicholas has overseen Virtus’s growth since 2006 to over $7bn of client assets held for clients in over 30 countries. He is a highly experienced fiduciary and investment practitioner, advising family offices and private clients in many jurisdictions. He regularly assists clients in the establishment and ongoing monitoring of complex multi manager client investment portfolios as well as advising on other assets such as real estate, art collections and other collectables. Previously he worked at N M Rothschild as a managing director within that group’s private wealth division. He holds a number of non-executive Board appointments including the London premium segment listed BH Global Limited and Carador Income Fund PLC as well as several real estate, specialist asset and investment funds. He is a Fellow of the Institute of Chartered Accountants in England and Wales.
Nigel is the Chairman and co-founder of Syncona Partners. He is also Chairman of Oxford University Innovation, the technology transfer group for Oxford University, and Chairman of the Oxford Academic Health Science Network, a new entity established by the National Health Service in England to align the interests of patients in its region with academia, industry and the healthcare system. He was previously Chairman of Laird plc for 14 years and Oxford Instruments plc for 16 years. His career has encompassed venture capital, industry and banking. He has a degree in engineering from Cambridge University, is a Fellow of the Institute of Chartered Accountants, a Fellow of the Institute of Engineering and Technology and has been involved in the formation and development of high technology businesses for more than thirty years. He is also the Chairman of the AIM listed medical device company, Deltex Medical plc.
Thomas Henderson has over 25 years’ experience working in the financial markets, investing in the UK, Europe, emerging markets and the United States. He is the founder and investment manager of New Generation Haldane Fund Management Limited (previously Eden Capital). Previously, Mr Henderson was a portfolio manager for Moore Capital and prior to that worked with Cazenove & Co. in London and New York.